Aspergillus and progression of lung disease in children with cystic fibrosis
Sabariah Noor Harun, Claire E Wainwright, Keith Grimwood, Stefanie Hennig, Joyce Cheney, Narelle George, Colin F Robertson, Rosemary Carzino, Marj Moodie, David S Armstrong, Peter J Cooper, A James Martin, Bruce Whitehead, Catherine A Byrnes, Harm A Tiddens, Nicholas Gailer, Katrina Jess, Peta Yarrow, Merilyn McArthur, Sam Forbes Show all
Thorax | BMJ PUBLISHING GROUP | Published : 2019
Awarded by National Health and Medical Research Council
The original AC FBAL study was supported by the National Health and Medical Research Council (grants 9937868 and 351541) and the Children's Hospital Foundation Queensland, Australia. The tobramycin inhalation solution and delivery system used throughout the AC FBAL study was supplied by Pathogenesis Corporation, Chiron Corporation and Novartis Pharmaceuticals Inc.